Organogenesis Holdings Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | $66.6M | $278.7M | $103.8M |
| FY2024 | — | $262.9M | $135.6M |
| FY2025 | — | $300.1M | $93.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | $66.6M | $278.7M | $103.8M |
| FY2024 | — | $262.9M | $135.6M |
| FY2025 | — | $300.1M | $93.7M |